Primary Hyperoxaluria Type 1 (PH1)

European Renal Association (ERA) 2025

Congress Details

calander4-7 June 2025 | Austria

locationVienna, Austria

The materials in this section are intended for UK healthcare professionals and include scientific and educational congress content related to lumasiran. The information contained in these presentations and posters was accurate at the time of presentation. Healthcare professionals should consult the current full Prescribing Information [for the most up-to-date information on indications, dosing, contraindications, warnings, and adverse reactions].

Oral

Congress Materials

ERA
icon Presentation Type
Presentation
location icon Location
Vienna, Austria
icon Title
Long-Term Efficacy and Safety in the 60-Month, Phase 3 ILLUMINATE-B Trial of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1

Associated Materials

American-Society-of-Nephrology-Houston-TX-Mobile

Primary Hyperoxaluria Type 1 (PH1)

American Society of Nephrology (ASN) 2025

6-9 November, 2025 TX

View Details
Preparation Date
March 2026
Job Code
MB-UK-00086
European-Society-for-Paediatric-Nephrology,Athens,Greece-Mobile

Primary Hyperoxaluria Type 1 (PH1)

European Society for Paediatric Nephrology (ESPN) 2025

15-18 October, 2025 Greece

View Details
Preparation Date
March 2026
Job Code
MB-UK-00085
International Paediatric Transplant Association (IPTA) 2025 Congress, Germany

Primary Hyperoxaluria Type 1 (PH1)

International Paediatric Transplant Association (IPTA) 2025

18-21 September 2025 Germany

View Details
Preparation Date
March 2026
Job Code
MB-UK-00088
European Society for Paediatric Urology (ESPU) 2025 Congress, Austria

Primary Hyperoxaluria Type 1 (PH1)

European Society for Paediatric Urology (ESPU) 2025

3-6 September 2025 AUSTRIA

View Details
Preparation Date
March 2026
Job Code
MB-UK-00089

Primary Hyperoxaluria Type 1 (PH1)

Efficacy and Safety of Lumasiran for Advanced Primary Hyperoxaluria Type 1: 24-Month Follow-Up of the Phase 3 Illuminate-C Trial

American Journal of Kidney Diseases

Author(s)

Anne-Laure Sellier-Leclerc, Daniella Magen, Hadas Shasha-Lavsky, et al

March 2025

Preparation Date
March 2026
Job Code
MB-UK-00171
International Paediatric Nephrology Association (IPNA) 2025 Congress, South Africa

Primary Hyperoxaluria Type 1 (PH1)

International Pediatric Nephrology Association (IPNA) 2025

19-23 February, 2025 SA

View Details
Preparation Date
March 2026
Job Code
MB-UK-00093
Preparation Date
March 2026
Job Code
MB-UK-00091